1. Introduction
Nickel is known as an allergenic metal. The frequency of allergic sensitivity of this metal permanently increases. Currently, the percentage of people allergic to nickel is ca. 18% [
1,
2]. Sensitivity to nickel could be caused by the presence of nickel in clothes, jewellery, dishes, spectacle frames, orthodontic materials or parts of implants [
3,
4]. Nickel ions absorbed by organism can be widely distributed. Their presence was confirmed in such peripheral tissues, such as hair and nails [
5,
6]. It means that nickel can penetrate throughout the organism and can pose toxic effects in all tissues. The mechanism of nickel influence on metallothionein synthesis seems to be dependent on transcription factor MTF-1 (Metalothionein Transcription Factor), which is essential for the activation of the metallothionein promoter [
7]. Metallothionein plas the major role in detoxification from metals. Metallothionein (MT) is present in four major forms and is synthesized in response to the exposure to toxic metal ions. Thiol groups bind metal ions, thus removing them from the active participation in metabolic reactions. This helps to sustain homeostasis by ion immobilization [
8].
While induction of metallothionein expression after exposure to nickel is known and described, studies in the context of metallothionein expression during orthodontic treatment in response to doses of metal ions released from orthodontic appliances is new. It was observed in hepatocytes [
9,
10,
11] and in lungs [
12]. The condition and the proper functioning of brain depend on zinc homeostasis in nervous tissue. All four MT major forms are responsible for zinc distribution in the neurons and glial elements and control the redox potential [
13]. The proper concentration of zinc is essential for prevention of an extensive number of disorders of the central nervous system. According to the recent findings, oral devices may pose disadvantageous effects, due to the release of metal ions in potentially toxic doses [
14].
We tested hypothesis that nickel increases metallothionein synthesis. Also the correlation between synthesis of metallothionein major form 1 and major form 2 was investigated. The potential differences in MT-1 and MT-2 expression, between the control and experimental group of animals—hypothesis 1 (H1), potential differences in MT-1 and MT-2 expression in the same tissue—hypothesis 2 (H2), potential differences in MT-1 and MT-2 expression between tissues—hypothesis 3 (H3)), were tested.
2. Materials and Methods
2.1. The SS Plates, the Animals and the Tissue Samples
The animal test was performed with the approval (120/2009) of the Ethical Committee of the Wroclaw University of Environmental and Life Sciences. Twenty-four pigs were divided into two groups: the control and the experimental group, each consisting of 12 animals.
Pigs from the experimental group received two plates, implanted on the inner side of both cheeks [
15]. The plates were placed on a plastic, polyethylene base, which protected the buccal epithelium from irritation. The plastic elements were placed on the external part of the cheeks. The steel wire was used for clamping plates with plastic bases to the cheeks. The plates were kept on the buccal side of the cheek for 6 months. The pig’s diet, water, and dietary supplements were according to standard conditions. During 6 months of exposure, the weight of pigs increased to 162.3 kg.
The metal elements, the equivalent of orthodontic appliance, were as follows: bands size 37+ (3M Unitek, Monrovia, CA, USA); the steel wire with a diameter of 0.047 inches used for clamping. The composition of the stainless steel alloy (316L) of the experimental plates for pigs was as follows: Fe 65%; Cr 17%; Ni 12%; Mo 2.5%; Mn < 2%; Si < 1%; P < 0.045%; C < 0.03% and S < 0.03% (3M Unitek). The total mass of one plate was 6.2380 g.
The liver, the lung, and the brain tissues were chosen for the examinations. The biopsies of these three tissues were taken post mortem from each pig, and frozen at −20 °C. The biopsy was made with ceramic knives to avoid contamination with SS particles/ions. Acid washed vials were used for storage to avoid contamination with trace elements. Each sample mass was about 100 g.
2.2. Tissue Homogenates, Total RNA Isolation and Quantification, and Reverse Transcription
Tissue homogenates were obtained from deeply frozen fragments of the liver, lung, and brain tissues, which were next minced to small pieces, and homogenized with a glass homogenizer in PBS (phosphate-buffered saline) on ice, in conditions preventing metallothionein oxidation. Next, the suspensions were subjected to ultrasonication for 30 s and centrifuged for 10 min at 1500× g in 4 °C. The supernatants were collected, and the yield of homogenization was estimated in 12% SDS-PAGE, while the protein concentration was determined spectrophotometrically. The supernatants were stored at −20 °C.
Total RNA was extracted from 200 mg of tissues by using TRIzol Reagent (Darmstadt, Germany) according to the manufacturer’s recommendations. The RNA pellet was dissolved in 20–30 μL of sterile diethylpyrocarbonate-treated Mili-Q water and quantified spectrophotometrically and in agarose gel electrophoresis. RNA samples were stored as an aqueous solution at −70 °C.
Single stranded complementary DNA (cDNA) was synthesized with oligo (dT) primers from 5 μg of total RNA using VerteKit (Novazym, Poznan, Poland) according to the manufacturer’s instruction.
2.3. Quantification of Metallothioneins Expression by Real Time PCR
Accumulation of PCR products was measured in Real-Time PCR by using MESA GREEN qPCR MasterMix Plus for SYBR
® Assay (Eurogentec, Seraing, Belgium). The sequences of primers for pig metallothionein were chosen in regions of a homological sequence with human metallothionein, as presented in
Table 1. The reaction was performed in DNA Engine Opticon
® 2 Real-Time Detection System (MJ Research, Bethesda, MD, USA) three times for each probe. Beta-actin was used as a housekeeping gene—β-actin—5′GAGGTAGTCAGTCAGGTCCC3′ and 3′GAAGATCAAGATCATCGC5′. Additionally, product identity was confirmed in agarose (Novazym) gel electrophoresis and visualized by ethidium bromide (Sigma Aldrich, Steinheim, Germany) staining under UV light.
All statistical analyses were performed using the STATISTICA 12 software (StatSoft, Inc., STATISTICA for Windows) using the analysis of variance (ANOVA).
2.4. Western Blot
Metallothioneins were detected by Rabbit IgG-anti-porcine MT1/2 (Santa Cruz Biotechnology, Dallas, TX, USA), while the Ag-Ab complexes were detected with mouse monoclonal IgG anty-rabbit-IgG coupled with alkaline phosphatase (Promega, Charbonnières-les-Bains, France).
2.5. ELISA
Quantification of MT-2 in liver homogenates was performed using the BlueGene MET2 ELISA Kit (BlueGene Biotech Co., Ltd., Shanghai, China). The determinations were carried out in 3-fold replications of 4-fold diluted samples. The concentration of MT-2 in tested probes was calculated from the standard curve.
2.6. Statistical Analysis
The results of the Shapiro-Wilk tests showed the necessity for use of a non-parametric test to analyze statistically significant differences—the Mann-Whitney U test—assuming the significance level p < 0.01.
3. Results
At the beginning of the experiments, the average weight of pigs was 29.0 ± 1.3 kg, while at the end of the experiment, it was 191.3 ± 10.4 kg. Post mortem sampling was performed for the following tissues: liver, lung and brain. The major forms of metallothionein were determined in liver, lung and brain tissues. The homogenates obtained from small pieces of tissues were tested in PAGE-SDS for successful lysis. The protein concentrations in all homogenates were measured and equated before PAGE-SDS and Western blot assays using Rabbit IgG-anti-porcine MT1/2 (Santa Cruz Biotechnology, Dallas, TX, USA). To interpret the significance of the differences between tissues in experimental and control groups of animals for their immunoreactivity, with a clear indication of tissues from tested animals, were discussed. The strongest reaction was observed in all liver samples, from both groups of animals, those from the control and the experimental group. The last two tested tissues (lung and brain) differed from the tissue of liver. The presence of reaction with specific anti-metallothionein—1/2 rabbit antibody appeared only in samples derived from the experimental group of animals. While this reaction was observed in all lung samples, the brain samples reacted to a small extent. The metallothionein was not detected in samples of lung and brain from the control group of animals.
The comparative studies of activity of genes in liver, lung and brain for both types of metallothionein were carried out on the cDNA library synthesized from total RNA isolated from the mentioned tissues. Obtained results were qualified after assessment of the melting curve.
Both forms of metallothionein (MT-1/2) were detected in the livers of all animals from both investigated groups. This does not reflect the possible impact of metal orthodontic appliance on the animal’s organism. Nevertheless, the responses obtained for samples of the lungs and the brain allow us to conclude on its influence on the synthesis metallothioneins.
The influence of metal ions released from orthodontic plate were detected, especially in lung. MT-1 and 2 were determined in lung samples from almost all animals of experimental group and were absent in samples from the control group. The samples of brain tissues only showed reactions in three cases from the experimental group and none from the control.
These data showed the influence of the metal plate on the synthesis of methallotionein in tissues that were not in contact and therefore the mechanism of its action should occur through the metal ions released from the metal plate and to the organism of pigs.
3.1. ELISA MT-2 in Liver Samples Determination
The determination of porcine MT-2 was performed in liver homogenates to detect the differences or their lack in the synthesis of this protein based on previous results by Western blots. This test showed the presence of metallothionein in the livers of all animals, but this technique did not allow for quantification of the detected protein. Obtained results showed almost equal MT-2 synthesis in both animal groups. The average MT-2 concentration in livers from the control group was 31 ng/mL, while in the experimental group, it was 29 ng/mL.
3.2. Real Time PCR
The statistical analysis concerned the differences in the activity of genes for metallothionein-1 and 2 observed: (i) between the control and the experimental group of animals—hypothesis 1 (H1) (
Table 2,
Figure 1); (ii) in the same tissue—hypothesis 2 (H2) (
Figure 2,
Table 3); and between organs i.e., liver, lung, and brain—hypothesis 3 (H3) (
Figure 3,
Table 4). The null hypothesis (H0)—when
p > 0.01—was the lack of significant differences between the analyzed samples. The test results are shown in
Table 2,
Table 3 and
Table 4. A box-whisker plot of the ordered
Qn values relative to the analyzed values is included.
Hypothesis 1, which assumed the differences between the experimental and the control groups of animals in gene expression of both metallothioneins, was positively verified. Such difference was demonstrated in the case of MT-2 gene expression in lung tissue. The expression of this gene in the experimental group was reduced (
Table 2 and
Figure 1).
Hypothesis 2, which assumed the differences in gene expression of both metallothioneins in the same tissue, was also positively verified (
Table 3 and
Figure 2).
Generally, large differences in the expression of MT-1 and MT-2 genes were noted in the case of two tissues—pulmonary and nervous. In both mentioned cases, the expression of the MT-1 gene significantly exceeded that of the MT-2 gene.
The activity of both metallothionein genes in the lungs of the experimental animals changed and decreased in comparison to the control group, which correlates with the results of H1. However, the MT-1 and MT-2 genes differ from each other significantly in their expression in the nervous tissue. There was no important difference in this parameter between the experimental and the control groups.
Hypothesis 3 assumed the appearance of differences in the expression of MT-1 and MT-2 genes between tissues in the same group of animals. The comparison of MT-1 and MT-2 gene expressions in lung, liver and brain in each group of animals showed the great differences (
Table 4 and
Figure 3).
The Western blot technique for simultaneous detection of two metallothioneins MT-1 and MT-2—showed the specific reaction in all three tested tissues, but the significant differences between them were noted (
Figure 4).
The largest differences were noted in the expression of the MT-1 gene in all the tissues, but they were almost identical in both groups of animals, which excluded the influence of implanted plate imitating an orthodontic appliance.
Indeed, the big difference, confirming the hypothesis 3, was shown by the comparison of the lungs and the brain in terms of MT-2 gene expression. The expression in the experimental group decreased in comparison to the control group.
Summarizing, the most significant change in metallothioneins genes expression occurred only in lung tissue and it mainly concerned MT-2 gene expression.
4. Discussion
The effect of metallic plate corresponding to orthodontic alloy on the expression and synthesis of two major forms of metallothionein—MT-1 and MT-2—in some tissues was influenced by the degree of specialization of tissue and its regenerative potential. In addition, the role of the organ was important. The following tissues were selected: (i) the liver, the organ of the body’s first line of defense against toxicants, endowed with a regenerative potential; (ii) the lungs, as the tissue of the body with conditioning experience, highly specialized, with the limited regenerative potential; and (iii) the brain, almost devoid of regenerative potential.
The conducted research showed that the lung tissue turned out to be the most sensitive to the potential toxic influence of metal ions. The studies showed differences in the expression of metallothioneins in individual tissues between the experimental and the control animals. According to the obtained results, the expression of both metallothioneins in the experimental and control groups, respectively, was as follows: lung: MT-1 1.04 vs. 1.11, MT-2 0.96 vs. 1.05, liver MT-1 0.89 vs. 0.91 vs. 1.12, MT-2 0.91 vs. 1.05, brain MT-1 1.24 vs. 1.20, and MT-2 0.955 vs. 0.945.The observed decrease in the expression of the MT-2 gene in the lungs was closely related with the increased concentration of this protein. Thus, the initial stimulatory effect, of the metal ions released from the plate, on the expression of the MT-2 gene in the lungs has already been extinguished, but its impact was visible in the elevated amount of MT-2 protein in this tissue.
Metallothionein-2 regulates calcium ions concentration and AKT phosphorylation in smooth muscle cells and MT-2 significantly decreases in asthmatic lung tissue [
16]. Metallothionein-2 is related to tissue and cell injury and plays the role in toxicological and chemotherapeutic activity of metal ions and nonmetal electrophiles and oxidants [
17]. MT-2 protein levels have been found to be more than 50% lower in asthmatic lung samples than in the control samples [
18].
There are published studies showing the MT expression as the prognostic factor or determining marker of different types of tumors. However, there are no constant and repeatable patterns in MT expression that predict cancer. Metallothioneins are upregulated in breast cancer, nasopharyngeal cancer, ovarian cancer, urinary bladder cancer, and melanoma [
19,
20,
21,
22,
23], while in other cases of cancer (hepatocellular carcinoma, prostate cancer, and papillary thyroid carcinoma), metallothionein expression is downregulated [
24,
25,
26].
The brain tissue seems to be the most resistant to the influence of metal ions released form the plate, because there were almost no changes in MT genes expression and its synthesis was not detected [
27]. However, there are evidences on MT participation in neurodegenerative diseases, as well as in brain disorders [
27].
The presence of metallothionein was found in all samples of the liver of both groups of animals and no difference in its concentration was confirmed with the ELISA technique. Metallothionein expression could be a useful marker for liver diseases. In acute liver toxicity caused by cadmium, carbon tetrachloride, or acetaminophen, MT plays a protective role. Analysis of MT gene expression in the liver with chronic hepatitis B patients is useful for the evaluation of disease progress. A downregulation of isoform MT-1 in hepatocellular carcinoma was observed in 63% of tumors [
28]. Hepatocytes have a high capacity to regenerate, even within few hours after an injury. The regenerating cells require zinc, which is delivered by metallothionein (MT). There are a lot of evidence that MT indicates an essential role for MT in liver cell regeneration [
29].
5. Conclusions
The results of our study indicate that prolonged exposure to nickel ions released from orthodontic metallic materials, based on tissue homogenates, total RNA isolation and quantification, and reverse transcription, produced observable effects. As a result of the conducted research, it was shown that chronic exposure to metal ions released from orthodontic appliances has an impact on the expression of metallothionein genes and the induction of protein synthesis. The induction of metallothionein, usually resulted in the presence of metals, could be also caused by many other stimuli, such as hormones, cytokines, inflammatory factors, and oxidative stress. The differences in MT genes activity and their protein synthesis indicated in our studies could be the preliminary data for the next studies classifying the safety of orthodontic metal materials in the future.
Author Contributions
Conceptualization, M.M. and K.C.; methodology, M.M., K.C., I.E.K., E.P.-A.; investigation, E.P.-A., I.E.K.; writing—original draft preparation, M.M., K.C., I.E.K.; funding acquisition, M.M. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by The National Centre for Research and Development in Poland, grant number (N R130006 10).
Institutional Review Board Statement
The animal test was performed with the approval (120/2009/09) of the Ethical Committee of the Wroclaw University of Environmental and Life Sciences.
Informed Consent Statement
Not applicable.
Data Availability Statement
The data presented in this study are available upon request from the corresponding author.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Thyssen, J.P.; Linneberg, A.; Menné, T.; Johansen, J.D. The epidemiology of contact allergy in the general population—Prevalence and main findings. Contact Dermat. 2007, 57, 287–299. [Google Scholar] [CrossRef]
- Uter, W.; Hegewald, J.; Aberer, W.; Ayala, F.; Bircher, A.J.; Brasch, J.; Coenraads, P.-J.; Schuttelaar, M.-L.A.; Elsner, P.; Fartasch, M.; et al. The European standard series in 9 European countries, 2002/2003—First results of the European Surveillance System on Contact Allergies. Contact Dermat. 2005, 53, 136–145. [Google Scholar] [CrossRef]
- Livideanu, C.; Giordano-Labadie, F.; Paul, C. Cellular phone addiction and allergic contact dermatitis to nickel. Contact Dermat. 2007, 57, 130–131. [Google Scholar] [CrossRef]
- Pazzini, C.A.; Pereira, L.J.; Peconick, A.P.; Marques, L.S.; Paiva, S.M. Nickel allergy: Blood and periodontal evaluation after orthodontic treatment. Acta Odontol. Latinoam. AOL 2016, 29, 42–48. [Google Scholar]
- Muchacka, R.; Kapusta, E.; Gren, A.; Formicki, G.; Kopańska, M.; Kraska, K.; Skomoruch, I.; Sosnówka-Czajka, E. Accumulation of metals in hair and nails of women smoking cigarettes. J. Microbiol. Biotechnol. Food Sci. 2013, 2, 18–23. [Google Scholar]
- Mikulewicz, M.; Wołowiec, P.; Loster, B.; Chojnacka, K. Metal ions released from fixed orthodontic appliance affect hair mineral content. Biol. Trace Elem. Res. 2015, 163, 11–18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Heuchel, R.; Radtke, R.; Georgiev, O.; Stark, G.; Aguet, M.; Schaffner, E. The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression. EMBO J. 1994, 13, 2870–2875. [Google Scholar] [CrossRef] [PubMed]
- Si, M.; Lang, J. The roles of metallothioneins in carcinogenesis. J. Hematol. Oncol. 2018, 11, 107. [Google Scholar] [CrossRef] [PubMed]
- Bauman, J.; Liu, J.; Klaassen, C. Production of metallothionein and heat-shock proteins in response to metals. Toxicol. Sci. 1993, 21, 15–22. [Google Scholar] [CrossRef]
- Sunderman, F., Jr.; Fraser, C. Effects of nickel chloride and diethyldithiocarbamate on metallothionein in rat liver and kidney. Ann. Clin. Lab. Sci. 1983, 13, 489–495. [Google Scholar]
- Sveikauskaite, I.; Sulinskiene, J.; Sadauskiene, I.; Ivanov, L. The effects of lead and nickel ions on total proteins and metallothioneins synthesis in mice liver. Biologija 2014, 60, 17–21. [Google Scholar] [CrossRef] [Green Version]
- McDowell, S.; Gammon, K.; Bachurski, C.K.; Wiest, J.S.; Leikauf, J.E.; Prows, D.R.; Leikauf, G.D. Differential gene expression in the initiation and progression of nickel-induced acute lung injury. Am. J. Respir. Cell Moll. Biol. 2000, 23, 466–474. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ebadi, M.; Iversen, P.; Hao, R.; Cerutis, D.R.; Rojas, P.; Happe, H.; Murrin, L.; Pfeiffer, R. Expression and regulation of brain metallothionein. Neurochem. Int. 1995, 27, 1–22. [Google Scholar] [CrossRef]
- Pagano, S.; Coniglio, M.; Valenti, C.; Negri, P.; Lombardo, G.; Costanzi, E.; Cianetti, S.; Montaseri, A.; Marinucci, L. Biological effects of resin monomers on oral cell populations: Descriptive analysis of literature. Eur. J. Paediatr. Dent. 2019, 20, 224–232. [Google Scholar] [PubMed]
- Mikulewicz, M.; Wołowiec, P.; Janeczek, M.; Gedrange, T.; Chojnacka, K. The release of metal ions from orthodontic appliances animal tests. Angle Orthod. 2014, 84, 673–679. [Google Scholar] [CrossRef] [PubMed]
- Ceylan-Isik, A.F.; LaCour, K.H.; Ren, J. Sex difference in cardiomyocyte function in normal and metallothionein trans-genic mice: The effect of diabetes mellitus. J. Appl. Physiol. 2006, 100, 1638–1646. [Google Scholar] [CrossRef] [PubMed]
- Namdarghanbari, M.; Wobig, W.; Krezoski, S.; Tabatabai, N.M.; Petering, D.H. Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy. J. Biol. Inorg. Chem. 2011, 16, 1087. [Google Scholar] [CrossRef] [PubMed]
- Yin, L.M.; Xu, Y.D.; Peng, L.L.; Duan, T.T.; Liu, J.Y.; Xu, Z.; Wang, W.Q.; Guan, N.; Han, X.J.; Li, H.Y.; et al. Transgelin-2 as a therapeutic target for asthmatic pulmonary resistance. Sci. Transl. Med. 2018, 10, eaam8604. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gomulkiewicz, A.; Podhorska-Okolow, M.; Szulc, R.; Smorag, Z.; Wojnar, A.; Zabel, M.; Dziegiel, P. Correlation be-tween metallothionein (MT) expression and selected prognostic factors in ductal breast cancers. Folia Histochem. et Cytobiol. 2010, 48, 242–248. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jayasurya, A.; Bay, B.H.; Yap, W.M.; Tan, N.G.; Tan, B.K. Proliferative potential in nasopharyngeal carcinoma: Correlations with metallothionein expression and tissue zinc levels. Carcinogenesis 2000, 21, 1809–1812. [Google Scholar] [CrossRef] [Green Version]
- Hengstler, J.G.; Pilch, H.; Schmidt, M.; Dahlenburg, H.; Sagemuller, J.; Schiffer, I.; Oesch, F.; Knapstein, P.G.; Kaina, B.; Tanner, B. Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis. Int. J. Cancer 2001, 95, 121–127. [Google Scholar] [CrossRef]
- Wulfing, C.; van Ahlen, H.; Eltze, E.; Piechota, H.; Hertle, L.; Schmid, K.W. Metallothionein in bladder cancer: Correla-tion of overexpression with poor outcome after chemotherapy. World J. Urol. 2007, 25, 199–205. [Google Scholar] [CrossRef]
- Weinlich, G.; Eisendle, K.; Hassler, E.; Baltaci, M.; Fritsch, P.O.; Zelger, B. Metallothionein-overexpression as a highly significant prognostic factor in melanoma: A prospective study on 1270 patients. Br. J. Cancer 2006, 94, 835–841. [Google Scholar] [CrossRef]
- Ferrario, C.; Lavagni, P.; Gariboldi, M.; Miranda, C.; Losa, M.; Cleris, L.; Formelli, F.; Pilotti, S.; Pierotti, M.A.; Greco, A. Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma. Lab. Investig. 2008, 88, 474–481. [Google Scholar] [CrossRef]
- Datta, J.; Majumder, S.; Kutay, H.; Motiwala, T.; Frankel, W.; Costa, R.; Cha, H.C.; MacDougald, O.A.; Jacob, S.T.; Ghoshal, K. Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through in-activation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade. Cancer Res. 2007, 67, 2736–2746. [Google Scholar] [CrossRef] [Green Version]
- Han, Y.C.; Zheng, Z.L.; Zuo, Z.H.; Yu, Y.P.; Chen, R.; Tseng, G.C.; Nelson, J.B.; Luo, J.H. Metallothionein 1 h tumour sup-pressor activity in prostate cancer is mediated by euchromatin methyltransferase 1. J. Pathol. 2013, 230, 184–193. [Google Scholar] [CrossRef] [PubMed]
- Juárez-Rebollar, D.; Rios, C.; Nava-Ruíz, C.; Méndez-Armenta, M. Metallothionein in Brain Disorders. Oxid. Med. Cell. Longev. 2017, 2017, 5828056. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nagamine, T.; Nakajima, K. Significance of metallothionein expression in liver disease. Curr. Pharm. Biotechnol. 2013, 14, 420–426. [Google Scholar] [CrossRef]
- Cherian, M.G.; Kang, Y.J. Metallothionein and liver cell regeneration. Exp. Biol. Med. 2006, 231, 138–144. [Google Scholar] [CrossRef] [PubMed]
| Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).